Chapter 1 Executive Summary
Chapter 2 Global Sleeping Aids Market: An Overview
2.1 Report Description and Research Scope
2.2 Research Methodology
2.2.1 Primary Research
2.2.2 Secondary Research and Internal Data Modeling
2.3 Analyst Credentials
Chapter 3 Major Players of the Global Sleeping Aids Market
3.1 Overview
3.2 Present and Forecast Competitive Scenario (2018 Vs 2025)
3.3 Global Sleeping Aids Market: Company Share Analysis
Chapter 4 Market Outline
4.1 Market Trend, Outlook and Forecast
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Impact Analysis
4.2.2 Restraints
4.2.2.1 Impact Analysis
4.2.3 Opportunities
4.3 Porter’s Five Forces Analysis
Chapter 5 Market by Product: Size and Forecast, 2016 – 2025
5.1 Overview
5.2 Mattresses and Pillows
5.2.1 Current Trend and Analysis
5.2.2 Market Size and Forecast
5.3 Sleep Laboratories
5.3.1 Current Trend and Analysis
5.3.2 Market Size and Forecast
5.4 Medication
5.4.1 Current Trend and Analysis
5.4.2 Market Size and Forecast
5.4.3 Prescription Based Drugs
5.4.3.1 Market Size and Forecast
5.4.4 Herbal Drugs
5.4.4.1 Market Size and Forecast
5.4.5 OTC Drugs
5.4.5.1 Market Size and Forecast
5.5 Sleep Apnea Devices
5.5.1 Current Trend and Analysis
5.5.2 Market Size and Forecast
5.6 Other Products
5.6.1 Current Trend and Analysis
5.6.2 Market Size and Forecast
Chapter 6 Market by Sleep Disorder: Market Size and Forecast, 2016 – 2025
6.1 Overview
6.2 Insomnia
6.2.1 Current Trend and Analysis
6.2.2 Market Size and Forecast
6.3 Sleep Apnea
6.3.1 Current Trend and Analysis
6.3.2 Market Size and Forecast
6.4 Restless Legs Syndrome
6.4.1 Current Trend and Analysis
6.4.2 Market Size and Forecast
6.5 Narcolepsy
6.5.1 Current Trend and Analysis
6.5.2 Market Size and Forecast
6.6 Sleep Walking
6.6.1 Current Trend and Analysis
6.6.2 Market Size and Forecast
6.7 Other Sleep Disorders
6.7.1 Current Trend and Analysis
6.7.2 Market Size and Forecast
Chapter 7 Market by Region/ Geography: Market Size and Forecast, 2016 – 2025
7.1 Overview
7.2 North America
7.2.1 Current Trend and Analysis
7.2.2 Market Size and Forecast
7.2.3 Regional Market Dynamics
7.2.3.1 Drivers
7.2.3.2 Restraints
7.2.3.3 Opportunities
7.2.4 U.S.
7.2.4.1 Market Size and Forecast
7.2.5 Canada
7.2.5.1 Market Size and Forecast
7.2.6 Mexico
7.2.6.1 Market Size and Forecast
7.3 Europe
7.3.1 Current Trend and Analysis
7.3.2 Market Size and Forecast
7.3.3 Regional Market Dynamics
7.3.3.1 Drivers
7.3.3.2 Restraints
7.3.3.3 Opportunities
7.3.4 U.K.
7.3.4.1 Market Size and Forecast
7.3.5 Germany
7.3.5.1 Market Size and Forecast
7.3.6 France
7.3.6.1 Market Size and Forecast
7.3.7 Italy
7.3.7.1 Market Size and Forecast
7.3.8 Rest of Europe
7.3.8.1 Market Size and Forecast
7.4 Asia-Pacific
7.4.1 Current Trend and Analysis
7.4.2 Market Size and Forecast
7.4.3 Regional Market Dynamics
7.4.3.1 Drivers
7.4.3.2 Restraints
7.4.3.3 Opportunities
7.4.4 China
7.4.4.1 Market Size and Forecast
7.4.5 Japan
7.4.5.1 Market Size and Forecast
7.4.6 India
7.4.6.1 Market Size and Forecast
7.4.7 South Korea
7.4.7.1 Market Size and Forecast
7.4.8 Rest of Asia-Pacific
7.4.8.1 Market Size and Forecast
7.5 Rest of the World (RoW)
7.5.1 Current Trend and Analysis
7.5.2 Market Size and Forecast
7.5.3 Regional Market Dynamics
7.5.3.1 Drivers
7.5.3.2 Restraints
7.5.3.3 Opportunities
7.5.4 South America
7.5.4.1 Market Size and Forecast
7.5.5 Middle East
7.5.5.1 Market Size and Forecast
7.5.6 Africa
7.5.6.1 Market Size and Forecast
Chapter 8 Company Profiles
8.1 Natus Medical Incorporated
8.2 Teva Pharmaceutical Industries Limited
8.3 Takeda Pharmaceutical Company Limited
8.4 Merck And Co., Sanofi
8.5 GlaxoSmithKline Plc.
8.6 Serta International
8.7 CareFusion Corporation
8.8 Pfizer
8.9 Compumedics Limited
Back to top